Bionano genomics news.

SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first peer-reviewed benchmarking study …Forward-Looking Statements of Bionano Genomics. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as ...SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it has entered into a definitive agreement to acquire BioDiscovery, Inc., a leading software company ...Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 31, 2022 · SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported certain unaudited preliminary financial and commercial highlights for the fourth quarter and fiscal year ended December 31, 2022. The Company’s full results for the fourth quarter and the fiscal year ended December 31, 2022 are not yet available.

The BioNano Genomics stock price gained 0.633% on the last trading day (Thursday, 30th Nov 2023), rising from $1.58 to $1.59.During the last trading day the stock fluctuated 12.66% from a day low at $1.58 to a day high of $1.78.The price has risen in 5 of the last 10 days and is up by 16.06% over the past 2 weeks. Volume has increased on …

NEW YORK (GenomeWeb) – Bionano Genomics has priced its initial public offering of 3.36 million units at $6.125 per unit, bringing in total gross proceeds of $20.58 million, and has started trading on the Nasdaq. Each unit consists of one share of common stock and a five-year warrant to purchase another share of common stock at $6.125.Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago.News Release Details « Back. Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies. Feb 22, 2023 | PDF Version. ... About Bionano Genomics. Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers …The company reported a 29% increase in Q3 2023 revenue compared to the same period in the previous year, reaching $9.3 million. The growth in revenue can be attributed to the continued expansion of Bionano’s installed base of Saphyr systems, which grew by 39% year-over-year. As of September 30, 2023, the company had a total of 301 …

SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the publication by scientists at Revvity Omics (formerly Perkin Elmer Genomics), Leiden University Medical Centre, Bombay Hospital, and UT Dallas, of the largest peer-reviewed study to date on the use of optical genome mapping (OGM) to …

For the last reported quarter, it was expected that Bionano Genomics, Inc. Would post a loss of $0.90 per share when it actually produced a loss of $1.24, delivering a surprise of -37.78%.

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023, at 4:30 p.m. Eastern Time to report financial results for the third quarter 2023 and to highlight recent corporate progress.. Conference Call & Webcast Details11 Jan 2023 ... Bionano Genomics (BNGO) is trending after announcing a publication showing that genome mapping can help in identifying breast cancer.Publication demonstrates that Saphyr can be powerful and easy to use for solid tumor analysis in cancer research and clinical testing. SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in a wide variety of solid tumor samples.Albino parakeets are those that exhibit a mutation in the color-producing portion of their genome. The gene that causes the mutation is called the ino gene. However, because there are two different basic colorations for parakeets—blue and...SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification ...

Bionano’s Stratys system for OGM offers increased throughput capabilities to address the needs of mid and high-volume ... Bionano Genomics, Inc. +1 (858) 888-7610 [email protected]. Investor ...Bionano Genomics (BNGO-8.48%) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Here's ...InvestorPlace - Stock Market News, Stock Advice & Trading Tips. After surging to an all-time high early in 2021, Bionano Genomics (NASDAQ: BNGO) stock is back down among the penny stocks.The first ...SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT).SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in Thompson and Thompson... Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 Globe Newswire • 26 days ago. Bionano said it expected revenue of $7.3 million to $7.5 million in the first quarter, representing an increase of 28% to 32%, year over year. That would also mean the 10th consecutive quarter of ...Nov 29, 2023 · News Sentiment Bionano Genomics has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies. News Coverage This Week

Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest BioNano Genomics Inc (BNGO) real-time quote, historical performance, charts, and other financial information to …News Release Details « Back. Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress. Aug 04, 2022 | PDF Version - 73% year-over-year revenue growth in Q2 2022 - Achieved all 1H 2022 ELEVATE! milestones - Strong balance sheet with $187.3 million in cash, cash equivalents, and …

Bionano Genomics' $2.1 million in cash in SVB accounts is part of $113.2 million in cash, cash equivalents and AFS securities. MarketWatch Mar 13, 2023 7:41am.SAN DIEGO, April 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the American Association for Cancer Research (AACR) Annual Meeting 2023 ...Bionano Genomics (NASDAQ:BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ...Nov 29, 2023 · SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication demonstrating the use of optical genome mapping (OGM) to identify structural variations (SVs) introduced by CRISPR-Cas9 gene editing of CD4+ T-cells that could potentially limit the therapeutic use of such edited cells. News Releases. Year. 2023. 14 Nov '23. Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual …Sep 23, 2022 · SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT). SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr. Michael ...In 2022, BNGO's revenue was $27.80 million, an increase of 54.62% compared to the previous year's $17.98 million. Losses were -$132.60 million, 83.1% more than in 2021. According to 4 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is $46.67, which is an increase of 2,853.80% from the latest …Latest BioNano Genomics Inc Stock News. As of November 24, 2023, BioNano Genomics Inc had a $56.3 million market capitalization, putting it in the 30th percentile of companies in the Advanced Medical Equipment & Technology industry. BioNano Genomics Inc does not have a meaningful P/E due to negative earnings over …

NEW YORK – Bionano Genomics' Chinese original equipment manufacturing (OEM) partner, Beijing Genome Precision Technology (BGPT), has obtained reagent class I registrations from China's National Medical Products Administration (NMPA) for Bionano's DNA extraction kit and labeling products, GenomeWeb has learned. At …

4 Agu 2023 ... Bionano Genomics, Inc. (BNGO) will effect a one-for-ten (1-10) ... Nasdaq offers customers the ability to self select news delivery across various ...

In the Medical Instruments & Supplies industry, which ranks 77 out of 146 industries, BioNano Genomics Inc ranks higher than 0% of stocks. BioNano Genomics …Visualize multiple tracks of genomic data for the at-a-glance context of variant calls. NₓClinical offers multi-platform integration by: Combining current and historical molecular data from array and sequencing for sample continuity. Comparing and contrasting outputs from multiple technologies to understand the underlying biology.Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress. 02 Nov '23. Thompson and Thompson Genetics and Genomics in Medicine Includes OGM …SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication demonstrating the use of optical genome …Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ...Let’s get ready to reconnect in Torino, Italy – stop by our booth #54! We’re on a mission to change the way the world sees the genome with genome mapping systems, nucleic acid purification solutions, analysis software, and clinical testing services. Come explore the genomic variation continuum, from SNVs to whole chromosomes, through our ... Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing ...SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the Association for Molecular Pathology (AMP) 2023 Annual Meeting and Expo ...SAN DIEGO, July 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System …Aug 7, 2023 · Bionano Genomics (NASDAQ: BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ...

4 Agu 2023 ... Bionano Genomics, Inc. (BNGO) will effect a one-for-ten (1-10) ... Nasdaq offers customers the ability to self select news delivery across various ...Aug 7, 2023 · Bionano Genomics (NASDAQ: BNGO) effected a 1-for-10 reverse stock split and announced that it will publish quarterly earnings on Aug. 9. Shares opened this morning at $4.73 each, a market ... Dr. Klint Rose is currently a fellow at Bionano Genomics after serving as the Chief Scientific Officer at Purigen Biosystems, acquired by Bionano Genomics in 2022. Klint co-founded Purigen and led the team that transformed isotachophoresis-based extraction into the Ionic Purification System platform of products.NEW YORK (GenomeWeb) – Bionano Genomics has priced its initial public offering of 3.36 million units at $6.125 per unit, bringing in total gross proceeds of $20.58 million, and has started trading on the Nasdaq. Each unit consists of one share of common stock and a five-year warrant to purchase another share of common stock at $6.125.Instagram:https://instagram. metatrader 5 stock brokerswhat is a telluridejumbo loan brokerstricolor auto sales Sep 28, 2023 · SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first peer-reviewed benchmarking study to compare optical genome mapping (OGM) to the current global standard in molecular analysis of constitutional genetic disorders, chromosomal microarray analysis (CMA). Story continues. SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding ... how much is a 1976 quarter dollar worthalcha Bionano Genomics (BNGO 4.40%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ... fidelity stock prices Nov 1, 2023 · SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023, at 4:30 p.m ... Q2 2023 revenue was $8.7 million , which represents a 30% increase over Q2 2022 Installed base of Saphyr ® systems totaled 281 as of June 30, 2023 , which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023 , which represents a 108% increase over theRead the latest breaking news from Bionano Genomics. Find out if Bionano Genomics is biased and reliable and if their media bias is left, center, or right. Get access to our best features. Get Started. Enable Notifications Browser Extension Show Grayscale Images. Wednesday, November 22, 2023 Set Location. US Edition. Home. …